Aryan Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 10-12-2024
- Paid Up Capital ₹ 2.39 M
as on 10-12-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.18 Cr
as on 10-12-2024
- Satisfied Charges ₹ 5.30 Cr
as on 10-12-2024
- Revenue -0.84%
(FY 2023)
- Profit -2.29%
(FY 2023)
- Ebitda 16.72%
(FY 2023)
- Net Worth 22.35%
(FY 2023)
- Total Assets 13.09%
(FY 2023)
About Aryan Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 2.39 M.
The company currently has active open charges totaling ₹5.18 Cr. The company has closed loans amounting to ₹5.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parmod Agarwal, Payoj Agarwal, and Sarika Agarwal serve as directors at the Company.
- CIN/LLPIN
U24232UR2005PTC030011
- Company No.
030011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- LocationUttranchal, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Aryan Biotech Private Limited offer?
Aryan Biotech Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Beauty Soap, Pet Furniture & Products, Pet Grooming Tools.
Who are the key members and board of directors at Aryan Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parmod Agarwal  | Director | 19-May-2005 | Current |
| Payoj Agarwal | Director | 19-May-2005 | Current |
| Sarika Agarwal | Director | 10-Jan-2013 | Current |
Financial Performance of Aryan Biotech.
Aryan Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.84% decrease. The company also saw a slight decrease in profitability, with a 2.29% decrease in profit. The company's net worth Soared by an impressive increase of 22.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aryan Biotech?
Unlock access to Aryan Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 14 Mar 2024 | ₹1.48 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Feb 2022 | ₹3.70 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Jun 2022 | ₹6.30 M | Satisfied |
How Many Employees Work at Aryan Biotech?
Aryan Biotech has a workforce of 18 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aryan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aryan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
